Over at TheGlobeAndMail.com, Timothy Caufield warns that "overly enthusiastic representations [of science] can mislead the public about the readiness of a technology for clinical application, thus generating unrealistic expectations. Hype can skew research funding and lead to misinformed policy debates. And it can have an impact on clinical decision-making. It may also facilitate the marketing of unproven therapies – a particularly significant problem for stem cell research."

Click here to read the entire article.